TUSTIN, Calif., May 19 /PRNewswire-FirstCall/ -- AMDL, Inc. (Amex: ADL), (http://www.amdl.com), a world leader in specialty pharmaceuticals with operations in Shenzhen, Jiangxi and Jilin, China, announced today its chief executive officer and senior management team will host a teleconference scheduled for Wednesday, May 21, at 1:15 p.m. Pacific (4:15 p.m. Eastern) to discuss the Company's first quarter financial results.
To access the live call, please dial 1-877-360-1705. The conference identification number for the operator is 48561333. In addition, this call will be available as an audio webcast that can be accessed through AMDL's web site at http://www.amdl.com by clicking on the home page and following webcast instructions. The Company's earnings release, issued May 15, 2008, and accompanying financial and operating information is accessible on the Company's web site.
AMDL, Inc. is a global specialty pharmaceutical company. The company is headquartered in Tustin, California with operations in Shenzhen, Jiangxi, and Jilin, China. Along with its subsidiary Jade Pharmaceutical Inc. (JPI), AMDL is devoted to the research, development, manufacture, and marketing of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products currently in China. The Company employs approximately 320 people in the U.S. and China. More information about AMDL and its products can be obtained at http://www.amdl.com.
About Jade Pharmaceutical:
JPI has access to the fastest growing pharmaceutical and consumer market in the world: China. AMDL, through its subsidiaries, Jade currently manufactures large volume injection fluids, tablets and other related products, holding licenses for 133 products. It also manufactures 107 generic, over the counter and supplemental pharmaceutical products under certified Chinese Good Manufacturing Practice (CGMP) standards.
IR Contact: Mr. Paul Knopick
|SOURCE AMDL, Inc.|
Copyright©2008 PR Newswire.
All rights reserved